PMID- 22669927 OWN - NLM STAT- MEDLINE DCOM- 20131219 LR - 20211021 IS - 1757-790X (Electronic) IS - 1757-790X (Linking) VI - 2012 DP - 2012 Jun 1 TI - Seizures and postictal stupor in a patient with uncontrolled Graves' hyperthyroidism. LID - 10.1136/bcr.02.2012.5929 [doi] LID - bcr0220125929 AB - A 16-year-old girl with a history of Graves' disease presented with two episodes of generalised tonic-clonic seizures, necessitating intensive care admission. Laboratory examination demonstrated a suppressed thyroid-stimulating hormone level with dramatically elevated free triiodothyronine, free thyroxine and thyroid-stimulating immunoglobulins. Cerebrospinal fluid analysis showed oligoclonal banding in the absence of pleocytosis, thyroid peroxidase antibodies or infection. Neuroimaging revealed the presence of a congenital arachnoid cyst in the right temporal lobe. Despite restoration of euthyroidism and administration of antiepileptic and antiviral drugs, neurological features persisted. Subsequently, intravenous corticoids were administered to exclude the contribution of an underlying autoimmune encephalopathy. The patient gradually recovered and, in retrospect, elevated serum N-methyl-D-aspartic acid-receptor (NMDA-R) antibodies were detected. Although this patient presented with an intracerebral arachnoid cyst that can act epileptogenic per se, the combination of prolonged postictal encephalopathy with unresponsiveness to antiepileptic measures, absence of focal epileptiform activity on EEG, response to corticoids and serum NMDA-R antibody positivity favours the diagnosis of autoimmune NMDA-R encephalitis in this case. FAU - De Leu, Nico AU - De Leu N AD - Department of Internal Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium. FAU - Unuane, David AU - Unuane D FAU - Poppe, Kris AU - Poppe K FAU - Velkeniers, Brigitte AU - Velkeniers B LA - eng PT - Case Reports PT - Journal Article DEP - 20120601 PL - England TA - BMJ Case Rep JT - BMJ case reports JID - 101526291 RN - 0 (Anticonvulsants) RN - 0 (Antithyroid Agents) RN - 9002-71-5 (Thyrotropin) RN - Q51BO43MG4 (Thyroxine) SB - IM MH - Adolescent MH - Anticonvulsants/*therapeutic use MH - Antithyroid Agents/*therapeutic use MH - Diagnosis, Differential MH - Drug Therapy, Combination MH - Electroencephalography MH - Female MH - Graves Disease/blood/*complications/drug therapy MH - Humans MH - Magnetic Resonance Imaging MH - Seizures/diagnosis/drug therapy/*etiology MH - Stupor/diagnosis/drug therapy/*etiology MH - Thyrotropin/blood MH - Thyroxine/blood PMC - PMC4542433 COIS- Competing interests: None. EDAT- 2012/06/07 06:00 MHDA- 2013/12/20 06:00 PMCR- 2014/06/01 CRDT- 2012/06/07 06:00 PHST- 2012/06/07 06:00 [entrez] PHST- 2012/06/07 06:00 [pubmed] PHST- 2013/12/20 06:00 [medline] PHST- 2014/06/01 00:00 [pmc-release] AID - bcr.02.2012.5929 [pii] AID - 10.1136/bcr.02.2012.5929 [doi] PST - epublish SO - BMJ Case Rep. 2012 Jun 1;2012:bcr0220125929. doi: 10.1136/bcr.02.2012.5929.